Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-21 6:06 pm Unchanged | 2024-12-31 | 13G | Surmodics, Inc. SRDX | Barclays PLC | 1,039,058 7.260% | 0 (Unchanged) | Filing History |
| 2025-03-19 4:00 pm Purchase | 2025-03-12 | 13D | Surmodics, Inc. SRDX | GAMCO INVESTORS INC. GBL | 392,575 2.800% | 392,575 (New Position) | Filing History |
| 2025-02-14 2:47 pm Purchase | 2024-12-31 | 13G | Surmodics, Inc. SRDX | Barclays PLC | 1,039,058 7.260% | 1,039,058 (New Position) | Filing History |
| 2025-02-13 4:23 pm Sale | 2024-12-31 | 13G | Surmodics, Inc. SRDX | Beryl Capital Management LLC | 237,584 1.700% | -820,980 (-77.56%) | Filing History |
| 2025-01-22 5:15 pm Purchase | 2025-01-21 | 13G | Surmodics, Inc. SRDX | SOLEUS CAPITAL MASTER FUND, L.P. | 739,060 5.200% | 101,362 (+15.89%) | Filing History |
| 2024-11-15 1:37 pm Purchase | 2024-09-30 | 13G | Surmodics, Inc. SRDX | ALLIANCEBERNSTEIN L.P. | 1,040,430 7.300% | 1,040,430 (New Position) | Filing History |
| 2024-11-14 3:36 pm Sale | 2024-09-30 | 13G | Surmodics, Inc. SRDX | SOLEUS CAPITAL MASTER FUND, L.P. | 637,698 4.500% | -134,002 (-17.36%) | Filing History |
| 2024-11-06 1:30 pm Sale | 2024-09-30 | 13G | Surmodics, Inc. SRDX | MORGAN STANLEY MS | 705,884 4.900% | -447,061 (-38.78%) | Filing History |
| 2024-10-23 10:43 am Sale | 2024-09-30 | 13G | Surmodics, Inc. SRDX | Trigran Investments, Inc. | 543,342 3.800% | -391,350 (-41.87%) | Filing History |
| 2024-10-23 10:42 am Sale | 2024-09-30 | 13G | Surmodics, Inc. SRDX | TRIGRAN INVESTMENTS LP | 141,221 1.000% | -569,034 (-80.12%) | Filing History |
| 2024-07-09 1:49 pm Sale | 2024-06-12 | 13G | Surmodics, Inc. SRDX | Trigran Investments, Inc. | 934,692 6.600% | -1,423,608 (-60.37%) | Filing History |
| 2024-06-10 4:57 pm Purchase | 2024-05-30 | 13G | Surmodics, Inc. SRDX | Beryl Capital Management LLC | 1,058,564 7.400% | 1,058,564 (New Position) | Filing History |
| 2024-02-13 5:15 pm Sale | 2023-12-29 | 13G | Surmodics, Inc. SRDX | The Vanguard Group | 859,287 6.040% | -125,624 (-12.75%) | Filing History |
| 2024-02-09 12:21 pm Purchase | 2023-12-31 | 13G | Surmodics, Inc. SRDX | MORGAN STANLEY MS | 1,152,945 8.100% | 1,152,945 (New Position) | Filing History |
| 2024-02-09 11:20 am Purchase | 2023-12-31 | 13G | Surmodics, Inc. SRDX | Trigran Investments, Inc. | 2,358,300 16.600% | 29,375 (+1.26%) | Filing History |
| 2024-02-02 09:53 am Sale | 2023-12-31 | 13G | Surmodics, Inc. SRDX | SOLEUS CAPITAL MASTER FUND, L.P. | 771,700 5.400% | -3,611 (-0.47%) | Filing History |
| 2024-01-29 4:29 pm Sale | 2023-12-31 | 13G | Surmodics, Inc. SRDX | Millennium Management LLC | 671,551 4.700% | -120,639 (-15.23%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Surmodics, Inc. SRDX | BlackRock Inc. BLK | 1,080,288 7.600% | 65,532 (+6.46%) | Filing History |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | Surmodics, Inc. SRDX | BlackRock Inc. BLK | 1,014,756 7.200% | -1,297,751 (-56.12%) | Filing History |
| 2023-03-20 4:43 pm Purchase | 2023-03-15 | 13G | Surmodics, Inc. SRDX | Millennium Management LLC | 792,190 5.600% | 792,190 (New Position) | Filing History |